X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2107) 2107
Publication (174) 174
Book / eBook (37) 37
Book Review (30) 30
Book Chapter (15) 15
Newsletter (8) 8
Newspaper Article (6) 6
Conference Proceeding (3) 3
Dissertation (3) 3
Magazine Article (3) 3
Government Document (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1892) 1892
female (1688) 1688
index medicus (925) 925
oncology (827) 827
ovarian neoplasms - blood supply (684) 684
animals (669) 669
ovarian cancer (664) 664
middle aged (628) 628
ovarian neoplasms - pathology (595) 595
cancer (589) 589
adult (569) 569
angiogenesis (504) 504
mice (428) 428
aged (417) 417
tumors (330) 330
cell line, tumor (324) 324
obstetrics & gynecology (322) 322
ovarian-cancer (299) 299
ovarian neoplasms - drug therapy (276) 276
ovarian neoplasms - metabolism (269) 269
metastasis (266) 266
expression (265) 265
endothelial growth-factor (251) 251
research (240) 240
ovarian neoplasms - diagnostic imaging (239) 239
chemotherapy (230) 230
ovary - blood supply (220) 220
carcinoma (209) 209
neovascularization, pathologic - pathology (209) 209
care and treatment (203) 203
prognosis (201) 201
mice, nude (198) 198
immunohistochemistry (197) 197
vascular endothelial growth factor (192) 192
neovascularization, pathologic - metabolism (191) 191
breast-cancer (189) 189
health aspects (179) 179
male (177) 177
aged, 80 and over (165) 165
diagnosis (161) 161
radiology, nuclear medicine & medical imaging (160) 160
neovascularization, pathologic - drug therapy (158) 158
ovarian neoplasms - genetics (158) 158
tumor angiogenesis (156) 156
apoptosis (148) 148
neovascularization, pathologic (146) 146
ovarian neoplasms - surgery (145) 145
medicine (141) 141
ovarian neoplasms - diagnosis (140) 140
article (133) 133
bevacizumab (133) 133
cancer therapies (133) 133
breast cancer (132) 132
xenograft model antitumor assays (132) 132
angiogenesis inhibitors - therapeutic use (131) 131
adolescent (129) 129
analysis (129) 129
surgery (129) 129
diagnosis, differential (127) 127
gene expression (127) 127
proteins (127) 127
cell biology (126) 126
research article (125) 125
cells (122) 122
neoplasms - blood supply (121) 121
neoplasm staging (120) 120
in-vivo (119) 119
antineoplastic agents - therapeutic use (115) 115
therapy (114) 114
vascular endothelial growth factor a - metabolism (112) 112
treatment outcome (111) 111
vegf (109) 109
neovascularization, pathologic - genetics (107) 107
genetic aspects (106) 106
angiogenesis inhibitors - pharmacology (104) 104
biochemistry & molecular biology (104) 104
signal transduction (104) 104
cell proliferation (103) 103
ultrasound (103) 103
ovarian carcinoma (102) 102
growth (99) 99
mice, inbred balb c (99) 99
pathology (99) 99
neoplasms - pathology (97) 97
development and progression (96) 96
neoplasms - drug therapy (95) 95
risk factors (95) 95
gene expression regulation, neoplastic (94) 94
in-vitro (93) 93
antineoplastic agents - pharmacology (92) 92
ultrasonography (92) 92
sensitivity and specificity (91) 91
medicine, research & experimental (90) 90
multidisciplinary sciences (90) 90
retrospective studies (89) 89
tumor cells, cultured (89) 89
women (89) 89
survival (88) 88
cell proliferation - drug effects (87) 87
pharmacology & pharmacy (85) 85
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2042) 2042
German (26) 26
Chinese (24) 24
Polish (18) 18
Russian (18) 18
Japanese (16) 16
French (14) 14
Spanish (8) 8
Italian (5) 5
Czech (3) 3
Portuguese (3) 3
Hebrew (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Endocrinology, ISSN 0013-7227, 2018, Volume 159, Issue 9, pp. 3268 - 3274
Improved molecular understanding of tumor microenvironment has resulted in the identification of various cancer cell targets for diagnostic and therapeutic... 
ANTIANGIOGENIC THERAPY | NEUROENDOCRINE TUMORS | FUNCTIONAL EXPRESSION | ENDOCRINOLOGY & METABOLISM | FOLLICLE-STIMULATING-HORMONE | GROWTH-FACTOR | MONOCLONAL-ANTIBODIES | IMMUNOHISTOCHEMICAL DETECTION | TUMOR BLOOD-VESSELS | EPITHELIAL OVARIAN-CANCER | LUTEINIZING-HORMONE | Neoplasms - metabolism | Prostatic Neoplasms - metabolism | Cell Proliferation | Receptors, FSH - immunology | Humans | Ovarian Neoplasms - pathology | Tumor Microenvironment | Male | Antineoplastic Agents - administration & dosage | Molecular Targeted Therapy | Sarcoma - blood supply | Breast Neoplasms - metabolism | Drug Delivery Systems | Antibodies, Monoclonal, Humanized | Female | Ovarian Neoplasms - metabolism | Ovarian Neoplasms - blood supply | Ovarian Neoplasms - drug therapy | Prostatic Neoplasms - drug therapy | Receptors, FSH - metabolism | Prostatic Neoplasms - blood supply | Prostatic Neoplasms - pathology | Neoplasm Invasiveness | Neoplasms - blood supply | Breast Neoplasms - blood supply | Sarcoma - drug therapy | Sarcoma - pathology | Breast Neoplasms - drug therapy | Neoplasms - drug therapy | Sarcoma - metabolism | Breast Neoplasms - pathology | Endothelium, Vascular - metabolism | Neoplasms - pathology | Cell Movement | Cell proliferation | Therapy | Ovarian carcinoma | Coupling agents | Arterioles | Epithelial cells | Menopause | Antibodies | Cancer therapies | Cell surface | Blood | Ovarian cancer | Angiogenesis | Capillaries | Localization | Follicle-stimulating hormone | Reproductive systems | Therapeutic applications | Markers | Glycoprotein | Blood vessels | Breast cancer | Pharmacology | Chemical compounds | Endothelial cells | Blood circulation | Diagnostic systems | Reproductive system | Solid tumors | Prostate cancer | Prostate | Cell migration | Tumors
Journal Article
Cancer Research, ISSN 0008-5472, 08/2011, Volume 71, Issue 15, pp. 5346 - 5356
Journal Article
Cancer Journal (United States), ISSN 1528-9117, 07/2015, Volume 21, Issue 4, pp. 274 - 283
The clinical circumstance of treating spontaneous metastatic disease, after resection of primary tumors, whether advanced/overt or microscopic in nature, is... 
antiangiogenic drugs | metronomic low-dose chemotherapy | spontaneous metastatic disease | experimental therapeutic investigations | 1ST-LINE TREATMENT | ANTITUMOR-ACTIVITY | PLUS PACLITAXEL | MOUSE MODELS | PHASE-III TRIAL | BREAST-CANCER | THERAPY | ONCOLOGY | HYPOXIA-INDUCIBLE FACTOR-1-ALPHA | DOUBLE-BLIND | ORAL TOPOTECAN | Neoplasm Transplantation | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Melanoma - blood supply | Administration, Metronomic | Humans | Ovarian Neoplasms - pathology | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Angiogenesis Inhibitors - administration & dosage | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Angiogenesis Inhibitors - therapeutic use | Female | Ovarian Neoplasms - blood supply | Drug Evaluation, Preclinical | Ovarian Neoplasms - drug therapy | Disease Models, Animal | Tumor Microenvironment - drug effects | Colorectal Neoplasms - blood supply | Neoplasms - blood supply | Breast Neoplasms - blood supply | Melanoma - pathology | Breast Neoplasms - drug therapy | Neoplasms - drug therapy | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Neovascularization, Pathologic - drug therapy | Melanoma - drug therapy | Cell Line, Tumor | Kidney Neoplasms - pathology | Mice | Colorectal Neoplasms - pathology | Kidney Neoplasms - drug therapy | Kidney Neoplasms - blood supply
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2015, Volume 56, pp. 131 - 143
Abstract The study of cancer initiation, growth, and metastasis has traditionally been focused on cancer cells, and the view that they proliferate due to... 
Hematology, Oncology and Palliative Medicine | Tumour microenvironment | Ovarian cancer | LYMPHOCYTE-ASSOCIATED ANTIGEN-4 | INFILTRATING LYMPHOCYTES | PHASE-II | OPEN-LABEL | RECURRENT OVARIAN | MYELOID CELLS | MAINTENANCE THERAPY | ONCOLOGY | CD8(+) T-LYMPHOCYTES | MACROPHAGE POLARIZATION | EPITHELIAL OVARIAN | Neoplasms, Glandular and Epithelial - blood supply | Humans | Neovascularization, Pathologic | Ovarian Neoplasms - pathology | Neoplasms, Glandular and Epithelial - metabolism | Drug Resistance, Neoplasm | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Neoplasms, Glandular and Epithelial - immunology | Angiogenesis Inhibitors - therapeutic use | Female | Ovarian Neoplasms - metabolism | Ovarian Neoplasms - blood supply | Ovarian Neoplasms - drug therapy | Fibroblasts - metabolism | Tumor Microenvironment - drug effects | Neoplasms, Glandular and Epithelial - pathology | Endothelial Cells - metabolism | Fibroblasts - pathology | Animals | Signal Transduction - drug effects | Tumor Burden - drug effects | Fibroblasts - drug effects | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Cell Proliferation - drug effects | Endothelial Cells - pathology | Endothelial Cells - drug effects | Ovarian Neoplasms - immunology | Chemotherapy | Relapse | RNA | Metastasis | Health aspects | Diseases | Cancer | tumor microenvironment
Journal Article
Cancer Research, ISSN 0008-5472, 06/2013, Volume 73, Issue 11, pp. 3347 - 3355
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2014, Volume 9, Issue 3, p. e91811
Background: We aimed to evaluate the clinical significance of microvessel density (MVD), lymphatic vessel density (LVD), and cancer-associated fibroblasts... 
HETEROGENEITY | SURVIVAL | MULTIDISCIPLINARY SCIENCES | BREAST CARCINOMAS | PTEN | MICROVESSEL DENSITY | STROMA | MUTATIONS | LYMPHATIC VESSEL DENSITY | TUMOR-GROWTH | EXPRESSION | Prognosis | Lung Neoplasms - mortality | Colorectal Neoplasms - genetics | Humans | Middle Aged | Neovascularization, Pathologic | Microvessels - pathology | Male | Ovarian Neoplasms - mortality | Liver Neoplasms - mortality | Actins - genetics | Ovarian Neoplasms - genetics | Lymphatic Vessels - blood supply | Ovarian Neoplasms - secondary | Lung Neoplasms - secondary | Aged, 80 and over | Peritoneal Neoplasms - blood supply | Adult | Female | Ovarian Neoplasms - blood supply | Liver Neoplasms - secondary | Lung Neoplasms - blood supply | Peritoneal Neoplasms - secondary | Colorectal Neoplasms - mortality | Lung Neoplasms - genetics | PTEN Phosphohydrolase - genetics | Colorectal Neoplasms - blood supply | Liver Neoplasms - genetics | Lymphatic Metastasis | Fibroblasts - pathology | Peritoneal Neoplasms - mortality | Liver Neoplasms - blood supply | Peritoneal Neoplasms - genetics | Lymphatic Vessels - pathology | Survival Analysis | Desmin - genetics | Aged | Biomarkers, Tumor - genetics | Colorectal Neoplasms - pathology | Immunohistochemistry | Cancer patients | Care and treatment | Metastasis | Muscle proteins | Colorectal cancer | Liver | Colorectal carcinoma | Regional analysis | Muscles | Smooth muscle | Patients | Desmin | Lymph nodes | Metastases | Studies | Pathology | Heterogeneity | Lungs | Actin | Rodents | Fibroblasts | Microenvironments | Microvasculature | Mutation | PTEN protein | Cancer | Peritoneum
Journal Article
Angiogenesis, ISSN 0969-6970, 3/2010, Volume 13, Issue 1, pp. 43 - 58
Journal Article
Cancer Research, ISSN 0008-5472, 05/2012, Volume 72, Issue 9, pp. 2162 - 2171
Journal Article
Journal Article